Truist Financial Corp Acquires 3,541 Shares of Astera Labs, Inc. $ALAB

Truist Financial Corp increased its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 10.1% during the 4th quarter, Holdings Channel reports. The firm owned 38,603 shares of the company’s stock after buying an additional 3,541 shares during the period. Truist Financial Corp’s holdings in Astera Labs were worth $6,422,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. Perigon Wealth Management LLC grew its stake in shares of Astera Labs by 6.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after purchasing an additional 73 shares during the last quarter. Clearstead Advisors LLC lifted its holdings in Astera Labs by 13.6% in the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after buying an additional 76 shares during the period. Sound Income Strategies LLC lifted its holdings in Astera Labs by 9.2% in the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after buying an additional 76 shares during the period. Venturi Wealth Management LLC lifted its holdings in Astera Labs by 2.6% in the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after buying an additional 84 shares during the period. Finally, Great Valley Advisor Group Inc. lifted its holdings in Astera Labs by 2.2% in the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after buying an additional 90 shares during the period. 60.47% of the stock is owned by institutional investors.

Insider Buying and Selling at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 3,757 shares of the business’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $175.12, for a total transaction of $657,925.84. Following the completion of the sale, the director owned 67,144 shares of the company’s stock, valued at $11,758,257.28. The trade was a 5.30% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 10,000 shares of the business’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the sale, the general counsel directly owned 118,084 shares of the company’s stock, valued at approximately $12,725,912.68. The trade was a 7.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 1,064,888 shares of company stock worth $150,764,723. 12.50% of the stock is currently owned by insiders.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: JPMorgan raised its price target on Astera Labs to $280 from $205 and kept an overweight rating, signaling strong confidence in further upside after the company’s latest results. Benzinga
• Positive Sentiment: Needham lifted its price target to $260, while other reports cited positive forecasts from JPMorgan and Stifel, adding to the bullish analyst momentum around ALAB. Astera Labs (NASDAQ:ALAB) Price Target Raised to $260.00 at Needham & Company LLC
• Positive Sentiment: Commentary around the stock highlighted Astera Labs as a long-term momentum name and a beneficiary of AI connectivity demand, suggesting investors see durable growth tied to datacenter buildouts and server interconnect products. Why Astera Labs, Inc. (ALAB) is a Top Momentum Stock for the Long-Term
• Positive Sentiment: Several pieces emphasized strong AI connectivity demand and Scorpio expansion, with upbeat takes on the company’s positioning in the datacenter market helping support the stock. Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised
• Neutral Sentiment: Post-earnings analysis was mixed: bulls pointed to strong growth, but critics noted rising costs, competition, and a premium valuation, which could cap near-term upside. Should Investors Buy, Hold, or Sell ALAB Stock Post Q1 Earnings?
• Neutral Sentiment: Astera Labs’ Q1 2026 earnings transcript kept attention on the company’s strong revenue growth and guidance, but the transcript itself does not add a new catalyst beyond the already reported results. Astera Labs (ALAB) Q1 2026 Earnings Transcript
• Negative Sentiment: The main downside risk is valuation: after a strong run and multiple target hikes, some investors may worry the stock already prices in a lot of future growth.

Astera Labs Trading Up 2.1%

NASDAQ:ALAB opened at $199.79 on Friday. Astera Labs, Inc. has a 12 month low of $69.26 and a 12 month high of $262.90. The company has a market cap of $34.25 billion, a PE ratio of 134.99, a price-to-earnings-growth ratio of 3.30 and a beta of 3.35. The company has a 50 day simple moving average of $143.77 and a two-hundred day simple moving average of $153.99.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the previous year, the firm posted $0.33 EPS. The firm’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts forecast that Astera Labs, Inc. will post 1.48 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have commented on ALAB shares. UBS Group started coverage on shares of Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective for the company. Roth Mkm restated a “buy” rating and issued a $275.00 price objective on shares of Astera Labs in a report on Wednesday. Barclays lifted their target price on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday. JPMorgan Chase & Co. lifted their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 target price for the company. Fifteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $229.65.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.